182 related articles for article (PubMed ID: 17717432)
21. Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.
Martinez A; Pittaluga S; Rudelius M; Davies-Hill T; Sebasigari D; Fountaine TJ; Hewitt S; Jaffe ES; Raffeld M
Am J Surg Pathol; 2008 Aug; 32(8):1190-200. PubMed ID: 18580679
[TBL] [Abstract][Full Text] [Related]
22. N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas.
Moretti L; Medeiros LJ; Kunkalla K; Williams MD; Singh RR; Vega F
Mod Pathol; 2012 Feb; 25(2):231-6. PubMed ID: 22037256
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of PAX5 and TdT by Merkel cell carcinoma and pulmonary small cell carcinoma: a potential diagnostic pitfall but useful discriminatory marker.
Kolhe R; Reid MD; Lee JR; Cohen C; Ramalingam P
Int J Clin Exp Pathol; 2013; 6(2):142-7. PubMed ID: 23329999
[TBL] [Abstract][Full Text] [Related]
24. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.
Torlakovic E; Torlakovic G; Nguyen PL; Brunning RD; Delabie J
Am J Surg Pathol; 2002 Oct; 26(10):1343-50. PubMed ID: 12360049
[TBL] [Abstract][Full Text] [Related]
25. Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic Utility.
Fu Z; Zuo C; Sheehan CE; Patil DT; Lin J; Yang Z; Lee H
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):454-460. PubMed ID: 29561272
[TBL] [Abstract][Full Text] [Related]
26. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.
Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B
Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262
[TBL] [Abstract][Full Text] [Related]
27. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.
Desouki MM; Post GR; Cherry D; Lazarchick J
Clin Med Res; 2010 Jul; 8(2):84-8. PubMed ID: 20660931
[TBL] [Abstract][Full Text] [Related]
28. The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease.
O'Brien P; Morin P; Ouellette RJ; Robichaud GA
Cancer Res; 2011 Dec; 71(24):7345-50. PubMed ID: 22127921
[TBL] [Abstract][Full Text] [Related]
29. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.
George TI; Wrede JE; Bangs CD; Cherry AM; Warnke RA; Arber DA
J Mol Diagn; 2005 Aug; 7(3):346-51. PubMed ID: 16049306
[TBL] [Abstract][Full Text] [Related]
30. Pax5--a critical inhibitor of plasma cell fate.
Nera KP; Lassila O
Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
[TBL] [Abstract][Full Text] [Related]
31. Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.
Gibson SE; Dong HY; Advani AS; Hsi ED
Am J Clin Pathol; 2006 Dec; 126(6):916-24. PubMed ID: 17074681
[TBL] [Abstract][Full Text] [Related]
32. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
[TBL] [Abstract][Full Text] [Related]
33. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.
Cattoretti G; Angelin-Duclos C; Shaknovich R; Zhou H; Wang D; Alobeid B
J Pathol; 2005 May; 206(1):76-86. PubMed ID: 15772984
[TBL] [Abstract][Full Text] [Related]
34. The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms.
Jensen KC; Higgins JP; Montgomery K; Kaygusuz G; van de Rijn M; Natkunam Y
Mod Pathol; 2007 Aug; 20(8):871-7. PubMed ID: 17529924
[TBL] [Abstract][Full Text] [Related]
35. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.
Feldman AL; Law ME; Inwards DJ; Dogan A; McClure RF; Macon WR
Mod Pathol; 2010 Apr; 23(4):593-602. PubMed ID: 20118907
[TBL] [Abstract][Full Text] [Related]
36. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.
Hart MR; Anderson DJ; Porter CC; Neff T; Levin M; Horwitz MS
PLoS Genet; 2018 Sep; 14(9):e1007642. PubMed ID: 30216339
[TBL] [Abstract][Full Text] [Related]
37. Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis.
Lazzi S; Bellan C; Onnis A; De Falco G; Sayed S; Kostopoulos I; Onorati M; D'Amuri A; Santopietro R; Vindigni C; Fabbri A; Righi S; Pileri S; Tosi P; Leoncini L
Hum Pathol; 2009 Sep; 40(9):1252-61. PubMed ID: 19368954
[TBL] [Abstract][Full Text] [Related]
38. Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).
Valbuena JR; Medeiros LJ; Rassidakis GZ; Hao S; Wu CD; Chen L; Lin P
Am J Clin Pathol; 2006 Aug; 126(2):235-40. PubMed ID: 16891199
[TBL] [Abstract][Full Text] [Related]
39. Expression of the diffuse B-cell lymphoma family molecule SWAP-70 in human B-cell neoplasms: immunohistochemical study of 86 cases.
Heerema AE; Abbey NW; Weinstein M; Herndier BG
Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):21-5. PubMed ID: 15163014
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
